We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+15.3%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$1.36B
Cap. Flow
+$146M
Cap. Flow %
1.38%
Top 10 Hldgs %
29.42%
Holding
618
New
18
Increased
256
Reduced
279
Closed
53

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$40.3M
2
XOM icon
ExxonMobil
XOM
+$26.7M
3
TSLA icon
Tesla
TSLA
+$20.2M
4
AAPL icon
Apple
AAPL
+$14.6M
5
COP icon
ConocoPhillips
COP
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 25.63%
2 Healthcare 13.36%
3 Consumer Discretionary 12.83%
4 Financials 12.67%
5 Communication Services 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POOL icon
401
Pool Corp
POOL
$6.06B
$4.69M 0.04%
+12,600
New +$4.39M
KMX icon
402
CarMax
KMX
$8.49B
$4.68M 0.04%
49,600
+2,200
+5% +$206K
EMN icon
403
Eastman Chemical
EMN
$7.53B
$4.67M 0.04%
46,610
+8,700
+23% +$807K
CAG icon
404
Conagra Brands
CAG
$7.21B
$4.67M 0.04%
128,706
+47,000
+58% +$1.7M
FNF icon
405
Fidelity National Financial
FNF
$11.7B
$4.56M 0.04%
121,339
+29,224
+32% +$986K
MAS icon
406
Masco
MAS
$13.6B
$4.55M 0.04%
82,915
+4,100
+5% +$226K
K
407
DELISTED
Kellanova
K
$4.55M 0.04%
77,931
+39,192
+101% +$2.36M
ABMD
408
DELISTED
Abiomed Inc
ABMD
$4.53M 0.04%
13,985
-300
-2% -$83K
GPC icon
409
Genuine Parts
GPC
$18.1B
$4.52M 0.04%
44,968
-12,900
-22% -$1.26M
SRPT icon
410
Sarepta Therapeutics
SRPT
$2.19B
$4.5M 0.04%
26,400
+400
+2% +$59.3K
NDAQ icon
411
Nasdaq
NDAQ
$49.9B
$4.5M 0.04%
101,682
-36,000
-26% -$1.52M
MOH icon
412
Molina Healthcare
MOH
$10.8B
$4.49M 0.04%
21,100
+7,100
+51% +$1.47M
DOC icon
413
Healthpeak Properties
DOC
$13.9B
$4.48M 0.04%
148,123
-9,500
-6% -$276K
MGM icon
414
MGM Resorts International
MGM
$9.87B
$4.48M 0.04%
142,056
+56,500
+66% +$1.45M
WY icon
415
Weyerhaeuser
WY
$16.1B
$4.45M 0.04%
132,652
-7,900
-6% -$238K
ULTA icon
416
Ulta Beauty
ULTA
$23.3B
$4.45M 0.04%
15,479
-700
-4% -$177K
VOYA icon
417
Voya Financial
VOYA
$9.28B
$4.43M 0.04%
75,320
-1,400
-2% -$75.9K
IPG
418
DELISTED
Interpublic Group of Companies
IPG
$4.42M 0.04%
188,076
+23,700
+14% +$497K
CHRW icon
419
C.H. Robinson
CHRW
$18.4B
$4.41M 0.04%
46,995
-4,400
-9% -$420K
ALV icon
420
Autoliv
ALV
$8.51B
$4.41M 0.04%
47,833
+21,900
+84% +$1.89M
PFG icon
421
Principal Financial Group
PFG
$25.3B
$4.4M 0.04%
88,750
-5,100
-5% -$234K
INCY icon
422
Incyte
INCY
$24.7B
$4.39M 0.04%
50,445
-4,700
-9% -$407K
NVR icon
423
NVR
NVR
$16.7B
$4.37M 0.04%
1,072
+500
+87% +$2.08M
EQH icon
424
Equitable Holdings
EQH
$14.7B
$4.36M 0.04%
170,397
+24,400
+17% +$571K
TIF
425
DELISTED
Tiffany & Co.
TIF
$4.36M 0.04%
33,148
-1,200
-3% -$154K

Similar funds

Fjarde Ap-fonden's Q4 2020 Portfolio in Review

As of Q4 2020, Fjarde Ap-fonden held 618 positions worth $10.5B, up 15% from $9.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fjarde Ap-fonden's Q4 2020 filing shows 18 new, 256 increased, 279 reduced and 53 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 79,100 shares worth $5.79M. The largest sale was Chevron, an estimated $40.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fjarde Ap-fonden's largest Q4 2020 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 79,100 shares worth $5.79M.
  • Fjarde Ap-fonden added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $169M increase.
  • Fjarde Ap-fonden's biggest Q4 2020 reduction was Tesla, cutting an estimated $20.2M.
  • Fjarde Ap-fonden fully exited Chevron in Q4 2020, selling an estimated $40.3M.
  • Fjarde Ap-fonden's ten largest holdings make up 29% of its $10.5B portfolio in Q4 2020.
  • Fjarde Ap-fonden opened 18 new positions and closed 53 in Q4 2020.
  • Fjarde Ap-fonden's portfolio value rose 15% quarter-over-quarter to $10.5B.

Based on Fjarde Ap-fonden's 13F filing for Q4 2020, filed 12 Feb 2021.